D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE)

The purpose of this study is to determine the best way to treat people on d4T (stavudine) with high levels of lactic acid. Switching from d4T to abacavir will be assessed. Adding riboflavin and thiami...

Lead sponsor: University of British Columbia•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETEDNA

Prevention of Dichloroacetate Toxicity

NCT00031161 · Acidosis, Lactic, Chronic Disease

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 25, 2008Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2/PHASE3

Enrollment80

Start dateAug 2001

Last updatedSep 25, 2008

Condition

Acidosis, Lactic

Locations shown

St. Paul's Hospital

Vancouver, British Columbia

Positive Care Clinic

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 25, 2008Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions